SiteOne Therapeutics Raises $15M

Bozeman, Montana-based SiteOne Therapeutics said on Friday that it has raised $15M in a Series B investment round. The funding was led by Amgen, and also included Next Frontier and other investors. SiteOne is developing no-opioid analgesics, aimed at treating chronic pain without causing addition. The company is led by President and CEO Stan E. Abel. More information »